• Carbapenemase Transmission in Enterobacter cloacae

  2026-08-07

  A 2025 BMC Microbiology study characterized carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates from eight teaching hospitals in Guangdong, China. Its integrated analysis of gene location, plasmid transfer, mobile genetic elements, and strain relatedness shows how blaNDM-1 can disseminate through both horizontal and vertical pathways.

• CB-839 (Telaglenastat): Precision Tool for Cancer Metabolism

  2026-08-07

  CB-839 (Telaglenastat) is redefining cancer metabolism research by enabling highly selective inhibition of glutaminase 1 and robust assessment of glutaminolysis dependency in diverse tumor models. This guide unpacks actionable workflows, advanced troubleshooting, and translational insights, spotlighting the compound's unique value for experimental and preclinical oncology studies.

• Applied Research with YC-1: sGC Activation & HIF-1α Inhibiti

  2026-08-06

  YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol is a dual-action small molecule that empowers cancer researchers to dissect hypoxia signaling and angiogenesis with precision. This guide details practical workflows, troubleshooting insights, and unique applications of APExBIO’s high-purity YC-1 to accelerate experimental discovery.

• Cefiderocol’s In Vitro Efficacy Against Resistant P. aerugin

  2026-08-06

  This large-scale European study demonstrates that cefiderocol maintains high in vitro activity against Pseudomonas aeruginosa and Acinetobacter spp., even among isolates resistant to meropenem and modern β-lactam/β-lactamase inhibitor combinations. The findings inform susceptibility testing strategies and underscore the urgent need for robust antibacterial agents targeting multidrug-resistant non-fermenters.

• Single-Dose Gepotidacin for Treating Uncomplicated Gonorrhea

  2026-08-05

  The referenced phase 2 trial demonstrates that single oral doses of Gepotidacin (GSK2140944) achieved ≥95% microbiological cure rates for uncomplicated urogenital gonorrhea. This innovation addresses a pressing need for new antibiotics against drug-resistant Neisseria gonorrhoeae, with clear implications for both clinical practice and antibacterial research.

• AM251: Streamlining CB1 Receptor Antagonist Assays in Resear

  2026-08-05

  AM251 is a nanomolar-potency CB1 receptor antagonist that empowers cannabinoid receptor research with precise modulation of endocannabinoid signaling. This guide translates advanced mechanistic insights into actionable workflows, troubleshooting strategies, and novel applications for metabolic and neuroscience research.

• PPM-18: Precision iNOS Inhibition and the Future of Inflamma

  2026-08-04

  Explore how PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide) enables ultra-selective iNOS inhibition and NF-κB pathway modulation for advanced inflammation and sepsis models. This article uniquely bridges mechanistic detail with practical assay design and cross-pathway insights.

• Rifampin in Translational Research: Mechanistic Leverage and

  2026-08-04

  This thought-leadership article explores how Rifampin, a rifamycin antibiotic, uniquely empowers translational researchers to dissect bacterial transcription, resistance mechanisms, and synthetic biology applications. We blend mechanistic detail with strategic guidance, integrate evidence from clinical and experimental studies, and provide actionable protocol parameters for robust, reproducible results. The article also contextualizes APExBIO’s Rifampin within the evolving competitive landscape and projects its future role in antibiotic drug research.

• Biotin Azide: Precision Biotinylation for Wnt Signaling Stud

  2026-08-03

  Harness Biotin Azide for high-specificity labeling of alkynylated biomolecules in cutting-edge lipid-protein interaction studies. See how optimized click chemistry workflows and robust troubleshooting can propel your Wnt/β-catenin and cholesterol signaling research.

• Superoxide Dismutase (SOD) Activity Assay Kit: Technical Wor

  2026-08-03

  The Superoxide Dismutase (SOD) Activity Assay Kit enables quantitative measurement of SOD enzyme activity in biological samples using a colorimetric method. It is optimized for research applications involving oxidative stress and antioxidative enzyme analysis, but is not intended for clinical diagnostics or mechanistic pathway studies.

• Haloprogin in Translational Antifungal Research: Mechanisms

  2026-08-02

  This thought-leadership article explores Haloprogin—1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene—as a pivotal tool in the modern translational mycology and antimicrobial research landscape. Bridging evidence from foundational and contemporary studies, we analyze molecular mechanisms, protocol optimization, and strategic deployment in infection models. The discussion uniquely synthesizes competitive differentiation, workflow guidance, and the translational outlook for Haloprogin, positioning it as a reference compound for dermatophyte, Candida, and Gram-positive bacterial research. Researchers are offered actionable insights and direct access to APExBIO’s rigorously characterized Haloprogin reagent.

• Synergistic In Vitro Effects of Temafloxacin Combinations on

  2026-08-01

  This study systematically evaluated the combined antibacterial effects of clarithromycin, temafloxacin, and ethambutol against clinical strains of Mycobacterium avium complex (MAC). The results demonstrate that drug combinations—especially the triple regimen—exert superior intracellular bactericidal activity compared to single agents, informing experimental design for intracellular infection models.

• Gepotidacin: Transforming Antibacterial Research Workflows

  2026-07-31

  Gepotidacin (GSK2140944) empowers researchers to directly address antibiotic resistance by targeting bacterial DNA replication with unparalleled specificity. Explore advanced workflows, troubleshooting strategies, and protocol enhancements that leverage this first-in-class bacterial type II topoisomerase inhibitor for robust, reproducible antibacterial research.

• 5X Protein Loading Buffer (Reducing): SDS-PAGE Protocol Guid

  2026-07-31

  5X Protein Loading Buffer (Reducing) provides thorough denaturation and disulfide bond reduction for SDS-PAGE, ensuring accurate protein separation by molecular weight. It is not suitable for workflows requiring preservation of native protein structure or non-reducing conditions.

• Forskolin as an Adenylate Cyclase Activator: Applied Workflo

  2026-07-30

  Forskolin is a gold-standard adenylate cyclase activator, uniquely suited for dissecting cAMP signaling and its physiological consequences in stem cell and neuroendocrine assays. This article translates cutting-edge mechanistic insights and protocol optimizations into practical, evidence-backed workflows, with troubleshooting tips tailored for advanced cellular models.

412 records 6/28 page Previous Next First page 上5页 678910 下5页 Last page